Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency
Conditions: Neuroendocrine Tumor; Carcinoid Syndrome Interventions: Dietary Supplement: Enterade®; Other: Functional Assessment of Chronic Illness Therapy for Patients with Diarrhea (version 4.0) Sponsors: Vanderbilt-Ingram Cancer Center; Entrinsic Health Solutions, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2019 Category: Research Source Type: clinical trials